(+)-JQ-1 is a highly potent and selective BET bromodomain BRD2/4 inhibitor that showed activity impairing mouse macrophage inflammatory response [1], activating HIV latency [2], and blocking the BET mediated acetylation and transcriptions of c-Myc [3].